Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death-Reference-Cited by-同舟云学术

Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death

Published:2023-04-24 Issue:9 Volume:66 Page:6263-6273
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Zhihang¹²,Tan Mixiao³,Su Wen¹,Huang Wenping¹²,Zhang Jie¹²,Jia Fuhao¹²,Cao Guoliang¹,Liu Xinyang¹,Song Haohao¹,Ran Haitao³^ORCID,Nie Guangjun¹^ORCID,Wang Hai¹²^ORCID

Affiliation:

1. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China

2. University of Chinese Academy of Sciences, Beijing 100049, China

3. The Second Affiliated Hospital of Chongqing Medical University & Chongqing Key Laboratory of Ultrasound Molecular Imaging, Chongqing 400010, China

Funder

Guangdong Province Introduction of Innovative R&D Team

National Natural Science Foundation of China

Chinese Academy of Sciences

GBA National Institute for Nanotechnology Innovation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link